Clinical trial
Serum Prevalence of Antibodies Anti-SARS-Cov-2 in Healthy Subjects and in Patients With Chronic Diseases in Pre-pandemic Blood Samples
NCT04712448 is registered in ClinicalTrials.gov with IRCCS San Raffaele Roma as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Serum Prevalence of Antibodies Anti-SARS-Cov-2 in Healthy Subjects and in Patients With Chronic Diseases in Pre-pandemic Blood Samples
- Lead sponsor
- IRCCS San Raffaele Roma
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- December 30, 2020
- Completion date
- December 30, 2024
- Enrollment
- 3,500 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
chronic disease, healthy